<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Ultimate Peptides Blog</title>
    <link>https://ultimatepeptides.org/blog</link>
    <description>Research peptide guides, protocols, and updates from Ultimate Peptides.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 08 Jul 2026 19:35:21 GMT</lastBuildDate>
    <item>
      <title>The FDA&apos;s July 2026 Peptide Hearing: What BPC-157, TB-500, Semax, and 4 Others Are Up For Review</title>
      <link>https://ultimatepeptides.org/blog/fda-2026-peptide-compounding-hearing</link>
      <description>The FDA&apos;s Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to review BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, and Epitalon for the 503A Bulk Drug Substances List. What it means, and what it doesn&apos;t. Research use only.</description>
      <pubDate>Wed, 08 Jul 2026 16:00:00 GMT</pubDate>
      <guid isPermaLink="false">fda-2026-peptide-compounding-hearing</guid>
    </item>
    <item>
      <title>GHK-Cu (Copper Peptide): What the Research Actually Shows</title>
      <link>https://ultimatepeptides.org/blog/ghk-cu-copper-peptide-research</link>
      <description>A research-grounded breakdown of GHK-Cu (copper peptide / Copper Tripeptide-1) — chemical profile, studied mechanism, and what the published literature actually reports. Research use only.</description>
      <pubDate>Tue, 07 Jul 2026 23:20:00 GMT</pubDate>
      <guid isPermaLink="false">ghk-cu-copper-peptide-research</guid>
    </item>
  </channel>
</rss>